Corporate Profile
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio.
Quarterly Results
Show allQ4 2020
- Presentation 598.7 KB
Q3 2020
- Presentation 462.2 KB
Q2 2020
- Presentation 483.4 KB
Q1 2020
- Presentation 619.9 KB
Stock Quote
Exchange
Price
Change
Volume
- Data as of 08/31/24 7:44 PM EDT
- Minimum 15 minutes delayed.
- Data Provided by Refinitiv.